| Style | Citing Format |
|---|---|
| MLA | Farrokhi M, Arjaki D. "Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder." NeuroImmunoModulation, vol. 24, no. 2, 2017, pp. 120-. |
| APA | Farrokhi M, Arjaki D (2017). Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder. NeuroImmunoModulation, 24(2), 120-. |
| Chicago | Farrokhi M, Arjaki D. "Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder." NeuroImmunoModulation 24, no. 2 (2017): 120-. |
| Harvard | Farrokhi M, Arjaki D (2017) 'Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder', NeuroImmunoModulation, 24(2), pp. 120-. |
| Vancouver | Farrokhi M, Arjaki D. Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder. NeuroImmunoModulation. 2017;24(2):120-. |
| BibTex | @article{ author = {Farrokhi M and Arjaki D}, title = {Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder}, journal = {NeuroImmunoModulation}, volume = {24}, number = {2}, pages = {120-}, year = {2017} } |
| RIS | TY - JOUR AU - Farrokhi M AU - Arjaki D TI - Statistical Comments on Cytokine and Chemokine Profiles in Patients With Neuromyelitis Optica Spectrum Disorder JO - NeuroImmunoModulation VL - 24 IS - 2 SP - 120 EP - PY - 2017 ER - |